Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice

https://doi.org/10.1016/S1357-2725(96)00131-8Get rights and content

Abstract

Impaired wound healing is a common complication of diabetes mellitus. The underlying pathophysiology of diabetes-impaired healing is poorly understood. In the present study we have compared cell proliferation rates, apoptosis (programmed cell death), the myofibroblast marker α-smooth muscle actin and procollagen I mRNA expression, between diabetic and control mice. Full-thickness skin wounds were made in non-obese diabetic (NOD) mice and C57B6 controls. NOD mice showed a marked retardation of wound healing at both 7 and 14 days after wounding. Comparison of cell proliferation rates 7 days after wounding, using 5-bromo-2′-deoxy-Uridine incorporation, showed higher rates of cell proliferation in controls (88.1 ± 12.8) than in NOD wounds (52.1 ± 9.9, p < 0.02, n= 4). Immunohistochemical detection of α-smooth muscle actin, showed a later onset in diabetic wounds, suggesting that wound contraction may be delayed in the diabetic animals. In situ hybridisation for α1(I) procollagen mRNA expression, showed reduced procollagen I expression in the diabetic wounds when compared with controls. Lastly, there appeared to be higher levels of apoptosis in diabetic wounds, shown by the terminal transferase mediated UTP nick end-labelling technique. Apoptotic cells were rare in control wounds confirming previous studies, which showed that apoptosis occurs late in normal wound healing as the wound matures into scar tissue. In conclusion, we hypothesize that reduced cell proliferation, retarded onset of the myofibroblast phenotype, reduced procollagen I mRNA expression and aberrant control of apoptotic cell death may contribute to impaired wound healing seen in this diabetic model.

Reference (36)

  • DarbyI. et al.

    α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing

    Lab. Invest.

    (1990)
  • DesmouliereA. et al.

    Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar

    Am. J. Pathol.

    (1995)
  • DyerD.G. et al.

    Accumulation of Maillard reaction products in skin collagen in diabetes and aging

    J. Clin. Invest.

    (1993)
  • FergusonM.W.J. et al.

    The histology of diabetic foot ulcers

    Diabetic Med.

    (1996)
  • FisherE. et al.

    Interaction of ascorbic acid and glucose on production of collagen and proteoglycan by fibroblasts

    Diabetes

    (1991)
  • GabbianiG. et al.

    Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction

    Experientia

    (1971)
  • GavrieliY. et al.

    Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

    J. Cell Biol.

    (1992)
  • GenoveseC. et al.

    Construction of DNA sequences complementary to rat α1 and α2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D

    Biochemistry

    (1984)
  • Cited by (171)

    • Macrophage regulation of angiogenesis in health and disease

      2021, Seminars in Cell and Developmental Biology
      Citation Excerpt :

      Conversely, pro-inflammatory macrophages make up 80% of the total cell number at the wound margins of mouse diabetic wounds and chronic venous ulcers seen in humans [98], resulting in excessive reactive oxygen species (ROS) [99], and pro-inflammatory cytokine production such as Il-1β, IL-17 and TNFα within these wounds [97,100]. Chronic wound patients in the clinic also present with high levels of pro-inflammatory cytokines such as TNFα in their wound exudate [101], which is linked to changes in expression of MMPs that increase ECM proteolysis, as well as increases in apoptotic load, both of which feedback to elevate inflammation and hence contribute to wound chronicity [102,103]. However, despite the increased number of macrophages in chronic wounds, angiogenesis is shown to be insufficient, with decreased capillary density and vascularity in diabetic wounds [104].

    • Autologously transplanted dermal fibroblasts improved diabetic wound in rat model

      2020, Acta Histochemica
      Citation Excerpt :

      In addition to fibroblasts in the wound area, there are studies showing that they originate from pericytes, smooth muscle cells, or bone marrow-derived circulating fibrocytes which are CD34+, CD45+ and collagen Type 1+ cells (Quan et al., 2004; Mori et al., 2005; Herzog and Bucala, 2010). Several studies have shown that myofibroblast differentiation is delayed and inadequate wound contraction occurs in diabetes (Darby et al., 1997; Achar et al., 2014; Cheing et al., 2014). In our study, 5-day wound healing in the experimental diabetes group showed that α-SMA expression was significantly decreased compared to the control group and that diabetes had a negative effect on myofibroblast cell differentiation.

    View all citing articles on Scopus
    View full text